Toxicity to neuroblastoma cells and spheroids of benzylguanidine conjugated to radionuclides with short-range emissions.
Open Access
- 1 June 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 77 (12) , 2061-2068
- https://doi.org/10.1038/bjc.1998.348
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- A metastatic neuroblastoma model in SCID miceInternational Journal of Cancer, 1996
- [211At]Methylene blue for targeted radiotherapy of human melanoma xenografts: Dose fractionation in the treatment of cutaneous tumoursEuropean Journal Of Cancer, 1996
- Radiolabelled mIBG in the treatment of neuroblastomaEuropean Journal Of Cancer, 1996
- A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatinEuropean Journal Of Cancer, 1995
- First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastomaEuropean Journal Of Cancer, 1995
- Multi-modality megatherapy with [131I]metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastomaEuropean Journal Of Cancer, 1995
- Meta-iodobenzylguanidine in childrenSeminars in Nuclear Medicine, 1993
- Programmed Cell Death Induced by CeramideScience, 1993
- Editorial: The treatment of neuroblastoma with131I-MIBGMedical and Pediatric Oncology, 1987
- The radiosensitivity of human neuroblastoma cells estimated from regrowth curves of multicellular tumour spheroidsThe British Journal of Radiology, 1985